Though antioxidants are good for your health, taking them in supplement form is often unnecessary and can pose risks. Here's ...

A device long used by adults to manage migraines was now available for children as young as eight years old, offering new ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a reader whose statin caused them to feel ill.

The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

It's not the only blood pressure medication recall to happen in recent months, but the FDA's concern appears to follow a common theme.

The biosimilar will be available in both subcutaneous and intravenous formulations and has nearly all the same indications as ...